Combinations of Riboflavin with Antiseptics for Tackling Staphylococcus aureus Methicillin Resistant Infections by Photodynamic Inactivation

Antibiotic-resistant pathogens, such as methicillin resistant Staphylococcus aureus (MRSA), pose significant challenges in managing chronic wound infections. Antibacterial photodynamic inactivation (aPDI) has emerged as an alternative to antibiotics by offering localized and resistance-independent bacterial elimination. Natural compounds with photosensitizing properties are particularly attractive due to their biocompatibility and sustainability. Therefore, this study investigates the potential of aPDI using riboflavin (RB), a vitamin and vital micronutrient commonly found in various animals and plants. RB is known to be a promising natural photosensitizer, capable of causing bacterial cell damage by reactive oxygen species (ROS) generation. Additionally, the potential synergistic combinations with the commonly used wound antiseptics, namely octenidine dihydrochloride (OCT) and polyhexamethylene biguanide (PHMB) against S. aureus clinical strain (MJMC568-B: MRSA) was assessed. The approach aimed to improve antiseptic effiency by reducing the necessary concentrations. The antibacterial efficacy of RB, OCT and PHMB were determined independently by minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The photodynamic activity of RB was assessed by irradiating with blue light (420 nm) using a light-emitting diode (LED) system and quantification through colony-forming unit (CFU) analysis. An evaluation of the potential synergistic interactions of RB-mediated aPDI, with OCT and PHMB was conducted by a disk diffusion assay, and a checkerboard assay. The results highlight the potential of combining aPDI with antiseptics to achieve enhanced antibacterial effects against S. aureus. This dual approach could offer a promising solution for managing chronic wound infections, reducing the reliance on traditional antibiotics, and mitigating the risk of resistance development.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-21
DOI
https://doi.org/10.5281/zenodo.16794998
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combinations of Riboflavin with Antiseptics for Tackling Staphylococcus aureus Methicillin Resistant Infections by Photodynamic Inactivation

Zenodo (CERN European Organization for Nuclear Research)
Photodynamic Therapy Research Studies
article

Combinations of Riboflavin with Antiseptics for Tackling Staphylococcus aureus Methicillin Resistant Infections by Photodynamic Inactivation

article en

Abstract

Antibiotic-resistant pathogens, such as methicillin resistant Staphylococcus aureus (MRSA), pose significant challenges in managing chronic wound infections. Antibacterial photodynamic inactivation (aPDI) has emerged as an alternative to antibiotics by offering localized and resistance-independent bacterial elimination. Natural compounds with photosensitizing properties are particularly attractive due to their biocompatibility and sustainability. Therefore, this study investigates the potential of aPDI using riboflavin (RB), a vitamin and vital micronutrient commonly found in various animals and plants. RB is known to be a promising natural photosensitizer, capable of causing bacterial cell damage by reactive oxygen species (ROS) generation. Additionally, the potential synergistic combinations with the commonly used wound antiseptics, namely octenidine dihydrochloride (OCT) and polyhexamethylene biguanide (PHMB) against S. aureus clinical strain (MJMC568-B: MRSA) was assessed. The approach aimed to improve antiseptic effiency by reducing the necessary concentrations. The antibacterial efficacy of RB, OCT and PHMB were determined independently by minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The photodynamic activity of RB was assessed by irradiating with blue light (420 nm) using a light-emitting diode (LED) system and quantification through colony-forming unit (CFU) analysis. An evaluation of the potential synergistic interactions of RB-mediated aPDI, with OCT and PHMB was conducted by a disk diffusion assay, and a checkerboard assay. The results highlight the potential of combining aPDI with antiseptics to achieve enhanced antibacterial effects against S. aureus. This dual approach could offer a promising solution for managing chronic wound infections, reducing the reliance on traditional antibiotics, and mitigating the risk of resistance development.

Zenodo (CERN European Organization for Nuclear Research)
Universidade do Porto (PT), National Institute of Health Dr. Ricardo Jorge (PT)
Responsible consumption and production
Openalex Percentile: Top 36%
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.